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Background: Our previous studies have demonstrated that vagal stimulation (VS) increases the 
survival of rats with chronic heart failure, and acetylcholine (ACh) plays a protective role in 
cardiomyocytes against prolonged hypoxia through a non-hypoxic induction pathway of 
PI3K/Akt/HIF-1α, and finally an acetylcholinesterase inhibitor, donepezil, an anti-Alzheimer’s 
disease drug, also prevents a progression of heart failure in rats with myocardial infarction. However, 
taken with evidence that vagal innervation is extremely poor in the left ventricle, there is a missing 
link between VS, ACh and donepezil, suggesting another source of ACh exists in the heart. 
Hypothesis: We assessed the hypothesis that ACh is produced by cardiomyocytes and ACh 
promotes its synthesis via a positive feedback system, which donepezil could modulate. 
Methods and Results: Rat primary cardiomyocytes expressed choline acetyltransferase (ChAT), a 
crucial enzyme for ACh synthesis and its signal was localized in cytoplasm. Vesicular ACh 
transporter (VAChT) was also detected in cytoplasm with the vesicular structure identified by 
immunogold electron microscopy, suggesting that cardiomyocytes possess crucial components for 
ACh synthesis. Intracellular ACh in rat cardiomyocytes was detected not only with physostigmine 
(5.2 ± 0.4 nM in cell lysates), but also with donepezil, both of which are acetylcholinesterase 
inhibitors. In response to exogenous ACh or pilocarpine, a muscarinic agonist, cardiomyocytes 
significantly increased the transcriptional activity of ChAT and ChAT protein expression, and 
consequently the intracellular ACh level was up-regulated to 255 ± 28 % (p < 0.05) by pilocarpine, 
suggesting an ACh-amplification mechanism. Surprisingly, donepezil elevated the ChAT prompter 
activity and ChAT protein expression, leading to an increase in the ACh level to 385 ± 103% (p < 
0.05) in cardiomyocytes in vitro.  
Conclusion: The present results suggest that cardiomyocytes have an ACh synthesis system that acts 
through a muscarinic receptor, which is positively modulated by cholinergic agents including 
donepezil. Such an ACh-amplification system in cardiomyocytes may be involved in the beneficial 
effects of VS on the cardiac ventricles. 
 
